Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Medalist Diversified REIT | MDRR | Mar 17, 2025 | 12.41 | +0.48 |
Medallion Bank F Pref | MBNKP | Mar 17, 2025 | 25.11 | -1.66 |
Medallion Financial | MFIN | Mar 17, 2025 | 8.77 | -1.68 |
MediaAlpha | MAX | Mar 17, 2025 | 9.63 | +3.55 |
Mediaco A | MDIA | Mar 17, 2025 | 1.15 | -1.71 |
Medical Properties Trust | MPW | Mar 17, 2025 | 6.03 | +2.73 |
MediciNova | MNOV | Mar 17, 2025 | 1.54 | -0.65 |
Medicus Pharma | MDCX | Mar 17, 2025 | 2.95 | -10.33 |
Medifast | MED | Mar 17, 2025 | 14.35 | +2.94 |
MEDIROM Healthcare Technologies ADR | MRM | Mar 17, 2025 | 0.59 | -15.47 |
MediWound | MDWD | Mar 17, 2025 | 19.09 | +2.97 |
Mednax | MD | Mar 17, 2025 | 14.24 | +3.79 |
Medpace | MEDP | Mar 17, 2025 | 326.34 | +0.43 |
Medtronic | MDT | Mar 17, 2025 | 93.35 | +0.30 |
Mega Matrix | MPU | Mar 17, 2025 | 0.50 | -2.75 |
Megacap 300 Growth Index ETF Vanguard | MGK | Mar 17, 2025 | 315.41 | +0.04 |
Megacap 300 Index ETF Vanguard | MGC | Mar 17, 2025 | 204.56 | +0.55 |
Megacap 300 Value Index ETF Vanguard | MGV | Mar 17, 2025 | 129.09 | +1.26 |
MEI Pharma | MEIP | Mar 17, 2025 | 2.31 | +0.26 |
Meihua International Medical Technologies | MHUA | Mar 17, 2025 | 0.34 | +6.66 |
MeiraGTx Holdings | MGTX | Mar 17, 2025 | 7.87 | +1.03 |
Meiwu Technology | WNW | Mar 17, 2025 | 0.14 | -3.61 |
Melar Acquisition I | MACI | Mar 17, 2025 | 10.22 | 0.00 |
Melar Acquisition I | MACIU | Mar 17, 2025 | 10.09 | 0.00 |
Melco Resorts & Entertainment ADR | MLCO | Mar 17, 2025 | 5.75 | +2.13 |
MercadoLibre | MELI | Mar 17, 2025 | 2 106.46 | +4.21 |
Mercantile Bank | MBWM | Mar 17, 2025 | 44.58 | -0.29 |
Mercer International | MERC | Mar 17, 2025 | 6.41 | +2.72 |
Merchants Bancorp | MBIN | Mar 17, 2025 | 38.28 | +1.00 |
Merchants Bancorp C Pref | MBINN | Mar 17, 2025 | 21.31 | -0.23 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.